Nephros Inc (NEPH) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $4.20 (-0.71%), Market cap $0.04B, P/E ratio 51.86, 52-week low–high $2.26 ~ $5.79.
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its pr
Financial statements, price targets, institutional (13F) holdings and related news for Nephros Inc are updated in real time on BlackAll Trade.
Nephros Inc trades at $4.20 (-0.71%). Real-time quotes and charts are available on BlackAll Trade.
Nephros Inc has a market cap of about $0.04B. Its P/E ratio is 51.86.
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used